Track topics on Twitter Track topics that are important to you
Chronic Kidney Disease CKD Pipeline Analysis gives comprehensive insight on the various drugs being developed for the treatment of CKD. The report covers all the drugs being developed in various phases Discovery, Preclinical, Clinical Marketing. The pipeline focuses on novel pharmacologic drugs regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies and RNAbased therapeutics, but excludes symptom relief drugs. The report also covers some of the hot targets in research for CKD treatments.
This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the CKD Drug market. The report also provide strategic insights on medicines that are likely to have an impact on CKD treatment space and potentially alter standards of care in CKD in the foreseeable future.
Current therapies are not effective and more than half of patients gradually face severe renal and cardiovascular complications, hence it provides a tremendous opportunity for upcoming therapies specific to CKD such as MAbs, stem cellbased and RNAbased therapies, which reverses disease course or slow down kidney deterioration.
Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells. Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...
Track and monitor developments in stem cell research and commercial development. Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry. BioPort...